iShares US Pharmaceuticals ETF
IHE
IHE
149 hedge funds and large institutions have $342M invested in iShares US Pharmaceuticals ETF in 2025 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 44 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
27% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 44
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $297K
Holders
149
Holding in Top 10
–
Calls
–
Puts
$297K
Top Buyers
| 1 | +$981K | |
| 2 | +$799K | |
| 3 | +$774K | |
| 4 |
Goldman Sachs
New York
|
+$529K |
| 5 |
Corient Private Wealth
Miami,
Florida
|
+$458K |
Top Sellers
| 1 | -$7.26M | |
| 2 | -$6.56M | |
| 3 | -$2.47M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.28M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.01M |
